Home/Filings/4/0001437749-24-012331
4//SEC Filing

Schoen Eric 4

Accession 0001437749-24-012331

CIK 0001069530other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:21 PM ET

Size

12.0 KB

Accession

0001437749-24-012331

Insider Transaction Report

Form 4
Period: 2024-04-17
Schoen Eric
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-17$22.00/sh+1,500$33,00021,300 total
  • Award

    Common Stock Warrant

    2024-01-03+7,9207,920 total
    Exercise: $33.00From: 2024-01-03Exp: 2024-05-07Common Stock (11,880 underlying)
  • Award

    Common Stock Warrant

    2024-01-03+800800 total(indirect: By limited liability corporation)
    Exercise: $33.00From: 2024-01-03Exp: 2024-05-07Common Stock (1,200 underlying)
  • Exercise/Conversion

    Common Stock Warrant

    2024-04-171,0006,920 total
    Exercise: $33.00From: 2024-01-03Exp: 2024-05-07Common Stock (1,500 underlying)
Holdings
  • Common Stock

    (indirect: By limited liability corporation)
    2,000
Footnotes (2)
  • [F1]Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.
  • [F2]Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1
  • filerCIK 0001532303

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:21 PM ET
Size
12.0 KB